pharmaceutical industry whistleblowers

Qui tam cases filed by whistleblowers don’t just result in financial recoveries — someitmes they reshape entire industries. United States ex rel. Franklin v. Parke-Davis (2004) is an example of such industry-shifting cases. The whistleblower in that case was Dr. David Franklin, a former medical liaison at Parke-Davis, a subsidiary of Warner-Lambert (later acquired by […]